21 – 40 of 327
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
(
- Contribution to journal › Article
-
Mark
Artificial Intelligence-based Assessment of Prostate Cancer Metastases in PET/CT
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Nuclear expression of pSTAT3Tyr705 and pSTAT3Ser727 in the stromal compartment of localized hormone-naïve prostate cancer
(
- Contribution to journal › Article
-
Mark
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
(
- Contribution to journal › Article
-
Mark
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
(
- Contribution to journal › Article
-
Mark
Isolation of Circulating Tumor Cells with Acoustophoresis : Towards a biomarker assay for prostate cancer
2022)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Aspects of PET-CT in prostate cancer. Protocol optimization, diagnostic accuracy, and dosimetry.
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Lymph swelling after radical prostatectomy and pelvic lymph node dissection
(
- Contribution to journal › Article
-
Mark
Learning curve for robot-assisted laparoscopic radical prostatectomy in a large prospective multicentre study
(
- Contribution to journal › Article
-
Mark
Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate Cancer
(
- Contribution to journal › Article
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
(
- Contribution to journal › Article
-
Mark
Diet and BMI Correlate with Metabolite Patterns Associated with Aggressive Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Biokinetics and dosimetry of 18F-PSMA-1007 in patients with prostate cancer
(
- Contribution to journal › Article
-
Mark
PSA : role in screening and monitoring patients with prostate cancer
2022) p.131-172(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Improved needle design to reduce the risk of infection in transrectal prostate biopsies
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing
(
- Contribution to journal › Article
-
Mark
Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial
(
- Contribution to journal › Article
-
Mark
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
(
- Contribution to journal › Article
-
Mark
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance
(
- Contribution to journal › Article